# Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/modified-gemcitabine-and-oxaliplatin-or-gemcitabine-cisplatin-in-unresectable/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Atul Sharma,Bidhu Kalyan Mohanti,Surendra Pal Chaudhary,V. Sreenivas,Ranjit Kumar Sahoo,Nootan Kumar Shukla,Sanjay Thulkar,Sujoy Pal,Surya V. Deo,Sushmita Pathy,Nihar Ranjan Dash,Sunil Kumar,Sushma Bhatnagar,Rakesh Kumar,Seema Mishra,Peush ‎Sahni,Venkateswaran K. Iyer,Vinod Raina |
| Citations | 73 |
| DOI | 10.1016/j.ejca.2019.10.004 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2984293721 |
| PMID | 31707181 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Seema Mishra](https://scholariq.org/researchers/seema-mishra/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.